ISMP Report Emphasizes High Incidence of Xarelto Injuries
A review of adverse event reporting to the FDA in 2015 conducted by the Institute for Safe Medication Practices (ISMP) has revealed that Xarelto (rivaroaban) and its side effects were connected to more cases of serious harm than any other drug included in the survey. The next-generation anticoagulant drug came... Read more »